Chemed Co. (NYSE:CHE) Shares Bought by Cabot Wealth Management Inc.

Cabot Wealth Management Inc. grew its stake in shares of Chemed Co. (NYSE:CHE) by 0.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 22,961 shares of the company’s stock after acquiring an additional 202 shares during the period. Chemed comprises about 1.7% of Cabot Wealth Management Inc.’s holdings, making the stock its 22nd biggest position. Cabot Wealth Management Inc.’s holdings in Chemed were worth $13,799,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Thrivent Financial for Lutherans increased its stake in shares of Chemed by 300.3% during the 2nd quarter. Thrivent Financial for Lutherans now owns 116,572 shares of the company’s stock worth $63,249,000 after purchasing an additional 87,449 shares in the last quarter. Impax Asset Management Group plc increased its stake in shares of Chemed by 19.5% during the 2nd quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after purchasing an additional 51,974 shares in the last quarter. ProShare Advisors LLC increased its stake in shares of Chemed by 6,288.9% during the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after purchasing an additional 49,808 shares in the last quarter. TD Asset Management Inc increased its stake in shares of Chemed by 23.9% during the 1st quarter. TD Asset Management Inc now owns 254,953 shares of the company’s stock worth $163,662,000 after purchasing an additional 49,176 shares in the last quarter. Finally, Los Angeles Capital Management LLC purchased a new position in shares of Chemed during the 1st quarter worth approximately $26,776,000. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Chemed news, Director George J. Walsh III sold 400 shares of Chemed stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total value of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company’s stock, valued at approximately $1,819,893.62. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director George J. Walsh III sold 400 shares of the business’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $597.47, for a total transaction of $238,988.00. Following the completion of the sale, the director now directly owns 3,046 shares of the company’s stock, valued at $1,819,893.62. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now directly owns 5,990 shares of the company’s stock, valued at $3,363,864.20. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 9,144 shares of company stock valued at $5,264,839. Company insiders own 3.32% of the company’s stock.

Chemed Stock Up 0.3 %

Shares of CHE traded up $1.70 during mid-day trading on Tuesday, reaching $601.97. 56,794 shares of the company’s stock were exchanged, compared to its average volume of 84,020. The company has a 50-day simple moving average of $581.32 and a two-hundred day simple moving average of $571.23. Chemed Co. has a 52-week low of $502.64 and a 52-week high of $654.62. The company has a market cap of $9.11 billion, a price-to-earnings ratio of 32.40, a PEG ratio of 2.44 and a beta of 0.44.

Chemed (NYSE:CHE) last released its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The firm had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a return on equity of 29.21% and a net margin of 12.88%. The firm’s revenue was up 7.6% on a year-over-year basis. During the same period in the previous year, the firm posted $4.71 earnings per share. As a group, equities research analysts predict that Chemed Co. will post 21.77 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Monday, August 12th were paid a $0.50 dividend. This is a boost from Chemed’s previous quarterly dividend of $0.40. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, August 12th. Chemed’s payout ratio is presently 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.